Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Beximco Pharmaceuticals Ltd (BXPH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
109.10 -0.30    -0.27%
30/05 - Delayed Data. Currency in BDT ( Disclaimer )
  • Volume: 109,993
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 107.10 - 112.90
Type:  Equity
Market:  Bangladesh
ISIN:  BD0453BXPH04 
S/N:  BXPHARMA
Beximco Pharmaceuticals 109.10 -0.30 -0.27%

BXPH Balance Sheet

 
Assess the latest Beximco Pharmaceuticals Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced BXPH Annual Report data, financial summaries and charts are available for Beximco Pharmaceuticals Ltd investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 21813.64 22143.79 20942.04 20875.85
Cash and Short Term Investments 1731.55 1345.81 1540.56 1301.94
Cash - - - -
Cash & Equivalents 1160.42 1095.81 943.88 1135.69
Short Term Investments 571.13 250 596.69 166.25
Total Receivables, Net 3758.68 7172.86 3671.22 3585.61
Accounts Receivables - Trade, Net 3758.68 3707.32 3671.22 3370
Total Inventory 13531.93 13394.76 13321.66 13472.55
Prepaid Expenses - - - 60.96
Other Current Assets, Total 2791.49 230.36 2408.6 2454.8
Total Assets 70223.29 70626.67 69351.58 69156.78
Property/Plant/Equipment, Total - Net 42903.94 42944.25 42894.67 42807.84
Property/Plant/Equipment, Total - Gross 59980.11 - 59216.36 59041.19
Accumulated Depreciation, Total -17076.17 - -16321.69 -16233.35
Goodwill, Net 674.57 674.57 674.57 674.57
Intangibles, Net 4748.98 4785.07 4766.82 4721.03
Long Term Investments 20.97 20.97 20.97 20.97
Note Receivable - Long Term - - - 215.62
Other Long Term Assets, Total - - - -
Other Assets, Total 13197.05 10225.82 12708.23 12564.5
Total Current Liabilities 12142.09 13600.66 11780.68 13265.02
Accounts Payable - - - 1618.27
Payable/Accrued - - - -
Accrued Expenses 1042.28 993.93 1032.59 2580.69
Notes Payable/Short Term Debt 4269.81 4228.69 4732.72 6621.17
Current Port. of LT Debt/Capital Leases 1554.34 1558.91 1468.44 1439.9
Other Current liabilities, Total 5275.66 6819.12 4546.93 1005
Total Liabilities 19812.72 21582.94 20164.23 21537.12
Total Long Term Debt 1603.82 1816.28 2306.72 2550.83
Long Term Debt 1270.52 1816.28 1949.5 2157.72
Capital Lease Obligations 333.29 - 357.22 393.12
Deferred Income Tax 2503.47 2521.28 2541.76 2550.5
Minority Interest 3939.52 3937.48 3953.45 3938.96
Other Liabilities, Total -4646 -7396.14 -8420.32 -11714.99
Total Equity 50410.58 49043.74 49187.35 47619.67
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 4461.12 4461.12 4461.12 4461.12
Additional Paid-In Capital 6959.11 6959.11 6959.11 6959.11
Retained Earnings (Accumulated Deficit) 33599.45 32233.68 32360.35 30806.19
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 5390.89 5389.82 5406.76 5393.24
Total Liabilities & Shareholders' Equity 70223.29 70626.67 69351.58 69156.78
Total Common Shares Outstanding 446.11 446.11 446.11 446.11
Total Preferred Shares Outstanding - - - -
* In Millions of BDT (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BXPH Price Commentary

Write your thoughts about Beximco Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Harun Rahman
Harun Rahman Jun 01, 2022 8:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
vv good n fundmantal company
Khoka Talukder
Khoka Talukder Apr 15, 2022 18:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
can i invest in this company at this moment?
Khoka Talukder
Khoka Talukder Apr 15, 2022 18:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
can i invest in this company at this moment?
Mohammad Nur
Mohammad Nur Nov 02, 2021 18:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how can i invest in this company?
Shaiket Chowdhury
Shaiket Chowdhury Feb 24, 2021 5:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You're late. It will only go down from here.
Eliash Zarin
Eliash Zarin Jan 24, 2021 1:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hammm
Shah Selimuzzaman
Shah Selimuzzaman Jan 20, 2021 10:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A stock worth of investing now, to get immense profit in coming months
Eliash Zarin
Eliash Zarin Jan 20, 2021 10:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hammmmm
Rofik Ali
Rofik Ali May 12, 2020 16:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
beximco PARACETAMOL is good stock but I'm confused about management???
Ranzu Sharifuzzamam
Ranzu Sharifuzzamam May 12, 2020 16:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no. 1 Pharma in Bangladesh
MD Mehedi Hasan
MD Mehedi Hasan May 12, 2020 16:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Right
Hasan Rahman
Hasan Rahman May 12, 2020 16:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Management is not efficient enough.I mean not enough dynamic to innovate new idea and also not enough efficient to maintain there current stretegic product portfolio.They are getting enough money by manipulating present political advantage as Proprietor of this pharma belongs to running Government's vital post. Getting Enough money by manipulating stock market and investing that in CGMP facilitate factory but unable to provide such level managerial efficiency.Their FailureGMG airlines fall downSP ceramics fall downBeximco Synthetis fall downand so many are up comming...after the conversion of present government
Rofik Ali
Rofik Ali May 12, 2020 16:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long as they pay my dividend and once drop my buying price I'll topup
Rofik Ali
Rofik Ali May 11, 2020 23:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
brought beximco PARACETAMOL long time a go in uk £0.05 and now £0.40p
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email